Company: IMNN
Filing Date: 2025-05-30
Form Type: PRE 14A
Source: 0001641172-25-013068
Chunk: 33

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: PRE 14A
Chunk 33
---
 vesting on the first and second anniversary of the date of the grant, subject in each case to the executive’s continued employment through the applicable vesting date and has a maximum term of ten years. However, vested options may terminate earlier in connection with a change in control transaction or a termination of the Named Executive Officer’s employment. Subject to any accelerated vesting that may apply in the circumstances, the unvested portion of the option will immediately terminate upon a termination of the Named Executive Officer’s employment.

Each share of restricted stock granted to Dr. Lindborg in 2024 is scheduled to fully vest on the first anniversary of the grant date, subject to the executive’s continued employment through the applicable vesting date. Subject to any accelerated vesting that may apply in the circumstances, the unvested portion of the restricted stock will immediately terminate upon the termination of the Named Executive Officer’s employment.

The following table sets forth the stock options and restricted stock shares granted to our named executive officers in the 2024 fiscal year.

| Named             
 Executive Officer |     | 2024    
 Stock   
 Options 
 Granted |         |     | 2024                            
 Restricted Stock Shares Granted |        |
| Stacy Lindborg    |     |         | 293,102 |     |                                 | 25,000 |
| Michael Tardugno  |     |         | 207,926 |     |                                 |      - |
| Corinne Le Goff   |     |         |       - |     |                                 |      - |
| Khursheed Anwer   |     |         |  90,653 |     |                                 |      - |
| David Gaiero      |     |         |       - |     |                                 |      - |
| Jeff Church       |     |         |  12,500 |     |                                 |      - |

| 28 |

2024 Outstanding Equity Awards at Year-End

The following table summarizes the number of shares of the Company’s common stock underlying outstanding equity incentive plan awards for each Named Executive Officer as of December 31, 2024. None of the Named Executive Officers held any other outstanding stock awards as of December 31, 2024.

| Name                  |     | Grant      
 Date       |     | Number                      
 of Shares or Units of Stock |        |    |     | Option        
 Awards        
 No.           
 of Securities 
 Underlying    
 Unexercised   
 Options (#)   
 Exercisable   |        |     | No.           
 of Securities